Fannie Mae (FNMA): The government would love to treat all l...

Featured News Placeholder

Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the Internation...

NASDAQ:TLSA

Stock Options

NEW to INVESTORSHUB

Fannie Mae (FNMA)

Reply Private New

Replies (2) Next 10 Prev Next

Robert from yahoo bd

Send PM

Followers	38
Posts	6174
Boards Moderated	0
Alias Born	07/18/2020

FREE
FNMA REPORT

Robert from yahoo bd

Re: LuLeVan post# 745995

Wednesday, 01/25/2023 4:02:19 PM

Wednesday, January 25, 2023 4:02:19 PM

The government would love to treat all legacy shareholders equally badly. Unfortunately this is not possible because JPS are contractually protected against dilution. The beating therefore goes to those who are least able to defend themselves.

So why would the federal government ever want to leave the status quo and if your answer is "to make mo' money to spend on a politicians latest pet project" than wouldn't a well timed legal challenge to the NWS prevent it?

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent FNMA News

Current Report Filing (8-k) • Edgar (US Regulatory) • 02/14/2023 12:27:31 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:31:58 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:31:28 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:22:27 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:21:06 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:17:16 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:01:39 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:59:22 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:56:03 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:49:15 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:39:16 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:32:23 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:30:30 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:23:43 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:15:26 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:09:21 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:54:56 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:48:45 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:44:05 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:34:01 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:33:23 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:27:05 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:13:11 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:11:51 PM
Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:04:46 PM

More FNMA News

InvestorsHub NewsWire

ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM

Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM

Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • TLSA • Mar 31, 2023 7:07 AM

ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM

Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM

OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM

Start posting your company's news

Only $200 per official company press release!